Deanne Miller
Chief Operating Officer bij IMMUTEP LIMITED
Vermogen: 809 998 $ op 31-03-2024
Profiel
Deanne Miller is currently the Co-Managing Director at Immutep GmbH and the COO, Secretary & General Counsel at Immutep Ltd.
She is also a Member of The Law Society of New South Wales.
Previously, she worked as an Associate Director at Westpac Banking Corp., a Manager-Legal & Compliance at Macquarie Group Ltd., and a Legal Counsel at RBC Investor Services Trust (Australia).
Ms. Miller completed her undergraduate and graduate degrees at The University of Sydney.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMUTEP LTD
0.27% | 22-08-2023 | 3 267 305 ( 0.27% ) | 809 998 $ | 31-03-2024 |
Actieve functies van Deanne Miller
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUTEP LIMITED | Chief Operating Officer | 01-11-2016 |
| The Law Society of New South Wales | Corporate Officer/Principal | - |
Immutep GmbH
 Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Chief Executive Officer | - |
Eerdere bekende functies van Deanne Miller
| Bedrijven | Functie | Einde |
|---|---|---|
| MACQUARIE GROUP LIMITED | Compliance Officer | - |
| RBC Investor Services Trust (Australia) | General Counsel | - |
| WESTPAC BANKING CORPORATION | Corporate Officer/Principal | - |
Opleiding van Deanne Miller
| The University of Sydney | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| WESTPAC BANKING CORPORATION | Finance |
| IMMUTEP LIMITED | Health Technology |
| MACQUARIE GROUP LIMITED | Finance |
| Bedrijven in privébezit | 3 |
|---|---|
| The Law Society of New South Wales | |
| RBC Investor Services Trust (Australia) | Finance |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Health Technology |
